48
Participants
Start Date
October 2, 2015
Primary Completion Date
October 19, 2016
Study Completion Date
October 19, 2016
BIIB092
See Arm Descriptions for dosing information.
Placebo
See Arm Descriptions for dosing information. (0.9% Sodium Chloride for Injection or 5% Dextrose Injection if Sodium Chloride is not available)
The University of Alabama at Birmingham, Birmingham
David Geffen School of Medicine at UCLA, Los Angeles
University of California San Diego, San Diego
University of California, San Francisco, Medical Center at Parnassus, San Francisco
Parkinsons Disease and Movement Disorders Center of Boca Raton, Boca Raton
University of Florida College of Medicine, Gainesville
University of South Florida, Tampa
The University of Chicago Department of Neurology, Chicago
University of Minnesota Medical School, Minneapolis
Robert Wood Johnson Medical School, New Brunswick
Columbia University Medical Center, New York
Hospital of the University of Pennsylvania, Philadelphia
The University of Texas Southwestern Medical Center, Dallas
Lead Sponsor
Biogen
INDUSTRY